SGLT-2 inhibitors induce apoptosis and DNA damage, reducing cancer cell proliferation [130,131,132,133,134,135,136,137] through mitochondrial membrane instability metabolic changes (oxidative phosphorylation, DNA synthesis, glycolysis, ATP and fatty acids level diminution, beta-oxidation, and ketone amount augmentation). This evidence concerns the gene SLC5A2 and cancer.